Citation Tools

Download PDFPDF

718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies

Download to a citation manager

Cite this article as:
Garmezy B, Kambhampati S, Curti B, et al
718 Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies